DE PEDIATRIC COBRE: MOLECULAR MECHANISMS IN PELIZAEUS MERZBACHER DISEASE

DE PEDIATRIC COBRE:Pelizaeus Merzbacher 病的分子机制

基本信息

  • 批准号:
    7610723
  • 负责人:
  • 金额:
    $ 14.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-01 至 2008-07-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Pelizaeus-Merzbacher disease (PMD), an X-linked leukodystrophy, is caused by defects of the proteolipid protein 1 gene (PLP1) that encodes the major CNS myelin protein. Approximately 60% of families have a genomic duplication that includes the PLP1 gene, and 15-20% of families have PLP1 point mutations. Studies in mice have shown that an increased dosage of PLP1 can account for disease pathogenesis. Further, studies have shown that mutations in noncoding regions can alter PLP1 expression levels or the ratio of the alternatively spliced forms PLP1 and DM20. Our long-term objective is to understand the molecular mechanisms involved in generating the PMD phenotype so rational treatments and improved diagnostic techniques can be developed. In the first aim, results on location, size, structure and sequence at the junctions of PMD duplications support the hypothesis that most are caused by a novel coupled homologous and nonhomologous mechanism. We will continue a combined cytogenetic, molecular, and in silico approach to refine our understanding of the mechanism. In the second aim, the hypothesis that the duplication structure affects expression of PLP1 is being tested by engineering different duplications into ES cell lines and analyzing the structural effects on gene expression before and after differentiation into oligodendrocytes. In the third aim, the hypothesis that some PMD mutations dysregulate splicing of PLP1 is being tested by using gene transfer and RNA-protein binding assays to investigate cis-acting elements and trans-acting factors involved in PLP1/DM20 alternative splicing. We have determined that exon and intron splicing enhancers and the relative strength of the PLP1 and DM20 donor splice sites play an important role in PLP1 alternative splicing. The results of these studies have greatest impact potential through their generalizability to other genomic and splicing diseases, which have only recently been recognized as important types of genetic disease.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 Pelizaeus-Merzbacher病(PMD)是一种X连锁脑白质营养不良,由编码主要CNS髓鞘蛋白的蛋白脂质蛋白1基因(PLP 1)缺陷引起。大约60%的家族具有包括PLP 1基因的基因组重复,并且15-20%的家族具有PLP 1点突变。对小鼠的研究表明,PLP 1剂量的增加可以解释疾病的发病机制。此外,研究表明,非编码区的突变可以改变PLP 1的表达水平或可变剪接形式PLP 1和DM 20的比例。我们的长期目标是了解参与产生PMD表型的分子机制,以便开发合理的治疗方法和改进的诊断技术。在第一个目标中,PMD重复的位置,大小,结构和序列的交界处的结果支持的假设,大多数是由一个新的耦合同源和非同源机制。我们将继续采用细胞遗传学、分子生物学和计算机模拟相结合的方法来完善我们对该机制的理解。在第二个目标中,重复结构影响PLP 1表达的假设正在通过将不同的重复结构工程化到ES细胞系中并分析在分化成少突胶质细胞之前和之后对基因表达的结构影响来测试。在第三个目标中,一些PMD突变失调PLP 1剪接的假设正在测试通过使用基因转移和RNA-蛋白质结合试验,以调查顺式作用元件和反式作用因子参与PLP 1/DM 20选择性剪接。我们已经确定外显子和内含子剪接增强子以及PLP 1和DM 20供体剪接位点的相对强度在PLP 1选择性剪接中起重要作用。这些研究的结果具有最大的影响潜力,因为它们可以推广到其他基因组和剪接疾病,这些疾病最近才被认为是重要的遗传疾病类型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Grace M. Hobson其他文献

CHARACTERIZATION OF A CHROMOSOMAL DUPLICATION IN THE PLP 1 LOCUS : A NEW MOUSE MODEL OF PELIZAEUS-MERZBACHER DISEASE by Kristi
PLP 1 位点染色体重复的表征:Pelizaeus-merzbacher 病的新小鼠模型 作者:Kristi
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kristi Clark;Grace M. Hobson;Patricia A. DeLeon;Grace M. Hobson;Erica Selva;Patrica DeLeon;Heather Keskeny;Linda Banser;Lauren Sakowski
  • 通讯作者:
    Lauren Sakowski

Grace M. Hobson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Grace M. Hobson', 18)}}的其他基金

DE PEDIATRIC COBRE: MOLECULAR MECHANISMS IN PELIZAEUS MERZBACHER DISEASE
DE PEDIATRIC COBRE:Pelizaeus Merzbacher 病的分子机制
  • 批准号:
    8168442
  • 财政年份:
    2010
  • 资助金额:
    $ 14.83万
  • 项目类别:
Molecular genetics of Pelizaeus-Merzbacher disease
Pelizaeus-Merzbacher 病的分子遗传学
  • 批准号:
    7994789
  • 财政年份:
    2009
  • 资助金额:
    $ 14.83万
  • 项目类别:
Molecular genetics of Pelizaeus-Merzbacher disease
Pelizaeus-Merzbacher 病的分子遗传学
  • 批准号:
    8399018
  • 财政年份:
    2009
  • 资助金额:
    $ 14.83万
  • 项目类别:
Molecular genetics of Pelizaeus-Merzbacher disease
Pelizaeus-Merzbacher 病的分子遗传学
  • 批准号:
    8206571
  • 财政年份:
    2009
  • 资助金额:
    $ 14.83万
  • 项目类别:
Molecular genetics of Pelizaeus-Merzbacher disease
Pelizaeus-Merzbacher 病的分子遗传学
  • 批准号:
    7913108
  • 财政年份:
    2009
  • 资助金额:
    $ 14.83万
  • 项目类别:
Molecular genetics of Pelizaeus-Merzbacher disease
Pelizaeus-Merzbacher 病的分子遗传学
  • 批准号:
    7755867
  • 财政年份:
    2009
  • 资助金额:
    $ 14.83万
  • 项目类别:
Molecular genetics of Pelizaeus-Merzbacher disease
Pelizaeus-Merzbacher 病的分子遗传学
  • 批准号:
    7585455
  • 财政年份:
    2009
  • 资助金额:
    $ 14.83万
  • 项目类别:
DE PEDIATRIC COBRE: MOLECULAR MECHANISMS IN PELIZAEUS MERZBACHER DISEASE
DE PEDIATRIC COBRE:Pelizaeus Merzbacher 病的分子机制
  • 批准号:
    7720951
  • 财政年份:
    2008
  • 资助金额:
    $ 14.83万
  • 项目类别:
DE PEDIATRIC COBRE: MOLECULAR MECHANISMS IN PELIZAEUS MERZBACHER DISEASE
DE PEDIATRIC COBRE:Pelizaeus Merzbacher 病的分子机制
  • 批准号:
    7382172
  • 财政年份:
    2006
  • 资助金额:
    $ 14.83万
  • 项目类别:
DE PEDIATRIC COBRE: MOLECULAR MECHANISMS IN PELIZAEUS MERZBACHER DISEASE
DE PEDIATRIC COBRE:Pelizaeus Merzbacher 病的分子机制
  • 批准号:
    7171397
  • 财政年份:
    2005
  • 资助金额:
    $ 14.83万
  • 项目类别:

相似海外基金

Mechanisms of Splice Site Selection in Health and Disease
健康和疾病中剪接位点选择的机制
  • 批准号:
    10797554
  • 财政年份:
    2023
  • 资助金额:
    $ 14.83万
  • 项目类别:
Quantitative and Predictive Analysis of 5' Splice Site Recognition by U1 snRNP using Massively Parallel Arrays
使用大规模并行阵列对 U1 snRNP 5 剪接位点识别进行定量和预测分析
  • 批准号:
    10460136
  • 财政年份:
    2021
  • 资助金额:
    $ 14.83万
  • 项目类别:
Quantitative and Predictive Analysis of 5' Splice Site Recognition by U1 snRNP using Massively Parallel Arrays
使用大规模并行阵列对 U1 snRNP 5 剪接位点识别进行定量和预测分析
  • 批准号:
    10311645
  • 财政年份:
    2021
  • 资助金额:
    $ 14.83万
  • 项目类别:
Uncovering Mechanisms of 5' Splice Site Fidelity
揭示 5 剪接位点保真度的机制
  • 批准号:
    10532793
  • 财政年份:
    2020
  • 资助金额:
    $ 14.83万
  • 项目类别:
How do RNA-binding proteins control splice site selection?
RNA 结合蛋白如何控制剪接位点选择?
  • 批准号:
    BB/T000627/1
  • 财政年份:
    2020
  • 资助金额:
    $ 14.83万
  • 项目类别:
    Research Grant
Mechanism of Splice Site Recognition by the U2AF/SF1 Protein Complex
U2AF/SF1 蛋白复合物的剪接位点识别机制
  • 批准号:
    553974-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 14.83万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Uncovering Mechanisms of 5' Splice Site Fidelity
揭示 5 剪接位点保真度的机制
  • 批准号:
    10316181
  • 财政年份:
    2020
  • 资助金额:
    $ 14.83万
  • 项目类别:
Mechanisms of Splice Site Selection in Health and Disease
健康和疾病中剪接位点选择的机制
  • 批准号:
    10769989
  • 财政年份:
    2019
  • 资助金额:
    $ 14.83万
  • 项目类别:
Mechanisms of Splice Site Selection in Health and Disease
健康和疾病中剪接位点选择的机制
  • 批准号:
    10808389
  • 财政年份:
    2019
  • 资助金额:
    $ 14.83万
  • 项目类别:
Mechanisms of Splice Site Selection in Health and Disease
健康和疾病中剪接位点选择的机制
  • 批准号:
    10585911
  • 财政年份:
    2019
  • 资助金额:
    $ 14.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了